+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Depression of canine cardiac adenylate cyclase activity by muscarinic cholinergic agonists evidence that the effect is mediated by acceleration of the rate of decay of enzyme activity



Depression of canine cardiac adenylate cyclase activity by muscarinic cholinergic agonists evidence that the effect is mediated by acceleration of the rate of decay of enzyme activity



Clinical Research 29(2): 244A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028060209

Download citation: RISBibTeXText


Related references

Inhibitory effects of muscarinic cholinergic agonists on the activity of adenylate cyclase in canine trachealis muscle. American Review of Respiratory Disease 133(4 Suppl.): A113, 1986

Muscarinic cholinergic-receptor stimulation of specific GTP hydrolysis related to adenylate cyclase activity in canine cardiac sarcolemma. Circulation Research 63(2): 340-350, 1988

Agonist regulation of adenylate cyclase activity in neuroblastoma glioma hybrid Ng108-15 cells transfected to co-express adenylate cyclase type Ii and the 2 -adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity. Biochemical Journal 318(3): 1033-1039, 1996

Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity. Biochemical Journal 318: 1033-1039, 1996

Muscarinic cholinergic inhibition of cardiac adenylate cyclase activity lack of effect of cholera toxin. Circulation Suppl. 60(2): II-200, 1979

Muscarinic cholinergic depression of adenylate cyclase activity in airway smooth muscle. Clinical Research 34(1): 108A, 1986

Gtp dependent inhibition of cardiac adenylate cyclase ec 4.6.1.1 by muscarinic cholinergic agonists. Naunyn Schmiedeberg's Archives of Pharmacology 310(2): 113-120, 1979

GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists. Naunyn-Schmiedeberg's Archives of Pharmacology 310(2): 113-119, 1979

Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes. Journal of Cyclic Nucleotide and Protein Phosphorylation Research 10(2): 197-210, 1985

Muscarinic receptor agonists inhibit cardiac adenylate cyclase activity in the presence of gdp beta s or gdp. FASEB Journal 4(7): A1985, 1990

Effects of muscarinic cholinergic receptor agonists on beta adrenergic and histamine h 2 receptor stimulated adenylate cyclase activity in guinea pig myo cardium. Clinical Research 30(4): 816A, 1982

Cardiac adenylate cyclase. II. Structure-activity relationships for the activation of rat ventricle adenylate cyclase by beta-adrenoceptor agonists. Biochemical Pharmacology 24(24): 2255-2261, 1975

Muscarinic cholinergic receptor mediated inhibitory transduction of adenylate cyclase activity in subcellular fractions from rat heart improved detection in sodium phosphate buffer. Molecular & Cellular Biochemistry 93(1): 35-46, 1990

Correlation between the binding parameters of muscarinic agonists and their inhibition of adenylate cyclase activity. Advances in Experimental Medicine and Biology 236: 265-276, 1988

Reconstitution of muscarinic cholinergic inhibition of adenylate cyclase activity in embryonic chick heart. Journal of the American College of Cardiology 9(2 Suppl. A): 134A, 1987